These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 10606967

  • 1. Pretreatment of mice with lipopolysaccharide (LPS) or IL-1beta exerts dose-dependent opposite effects on Shiga toxin-2 lethality.
    Palermo M, Alves-Rosa F, Rubel C, Fernández GC, Fernández-Alonso G, Alberto F, Rivas M, Isturiz M.
    Clin Exp Immunol; 2000 Jan; 119(1):77-83. PubMed ID: 10606967
    [Abstract] [Full Text] [Related]

  • 2. Depletion of liver and splenic macrophages reduces the lethality of Shiga toxin-2 in a mouse model.
    Palermo MS, Alves Rosa MF, Van Rooijen N, Isturiz MA.
    Clin Exp Immunol; 1999 Jun; 116(3):462-7. PubMed ID: 10361235
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. LPS-primed CD11b+ leukocytes serve as an effective carrier of Shiga toxin 2 to cause hemolytic uremic syndrome in mice.
    Niu S, Paluszynski J, Bian Z, Shi L, Kidder K, Liu Y.
    Sci Rep; 2018 Mar 05; 8(1):3994. PubMed ID: 29507316
    [Abstract] [Full Text] [Related]

  • 5. Tolerance to lipopolysaccharide (LPS) regulates the endotoxin effects on Shiga toxin-2 lethality.
    Alves-Rosa F, Beigier-Bompadre M, Fernández G, Barrionuevo P, Mari L, Palermo M, Isturiz M.
    Immunol Lett; 2001 Mar 01; 76(2):125-31. PubMed ID: 11274731
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Shiga toxin-2 induces neutrophilia and neutrophil activation in a murine model of hemolytic uremic syndrome.
    Fernández GC, Rubel C, Dran G, Gómez S, Isturiz MA, Palermo MS.
    Clin Immunol; 2000 Jun 01; 95(3):227-34. PubMed ID: 10866130
    [Abstract] [Full Text] [Related]

  • 8. Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in Shiga toxin type 2-induced neutrophilia.
    Fernandez GC, Lopez MF, Gomez SA, Ramos MV, Bentancor LV, Fernandez-Brando RJ, Landoni VI, Dran GI, Meiss R, Isturiz MA, Palermo MS.
    Clin Exp Immunol; 2006 Oct 01; 146(1):76-84. PubMed ID: 16968401
    [Abstract] [Full Text] [Related]

  • 9. Neutrophil Extracellular Traps Induced by Shiga Toxin and Lipopolysaccharide-Treated Platelets Exacerbate Endothelial Cell Damage.
    Landoni VI, Pittaluga JR, Carestia A, Castillo LA, Nebel MC, Martire-Greco D, Birnberg-Weiss F, Schattner M, Schierloh P, Fernández GC.
    Front Cell Infect Microbiol; 2022 Oct 01; 12():897019. PubMed ID: 35811684
    [Abstract] [Full Text] [Related]

  • 10. Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages.
    Tesh VL, Ramegowda B, Samuel JE.
    Infect Immun; 1994 Nov 01; 62(11):5085-94. PubMed ID: 7927791
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Development of a Mouse Model of Shiga Toxin 2 (Stx2) Intoxication for Testing Therapeutic Agents Against Hemolytic Uremic Syndrome (HUS).
    Mejias MP, Fernandez-Brando RJ, Ramos MV, Abrey-Recalde MJ, Zotta E, Meiss R, Palermo MS.
    Curr Pharm Des; 2016 Nov 01; 22(34):5294-5299. PubMed ID: 27356777
    [Abstract] [Full Text] [Related]

  • 13. Endogenous glucocorticoids modulate neutrophil function in a murine model of haemolytic uraemic syndrome.
    Gómez SA, Fernández GC, Camerano G, Dran G, Rosa FA, Barrionuevo P, Isturiz MA, Palermo MS.
    Clin Exp Immunol; 2005 Jan 01; 139(1):65-73. PubMed ID: 15606615
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sensitization of human umbilical vein endothelial cells to Shiga toxin: involvement of protein kinase C and NF-kappaB.
    Louise CB, Tran MC, Obrig TG.
    Infect Immun; 1997 Aug 01; 65(8):3337-44. PubMed ID: 9234795
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Shiga toxin-1 regulation of cytokine production by human proximal tubule cells.
    Hughes AK, Stricklett PK, Kohan DE.
    Kidney Int; 1998 Oct 01; 54(4):1093-106. PubMed ID: 9767525
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hemolytically active (acylated) alpha-hemolysin elicits interleukin-1beta (IL-1beta) but augments the lethality of Escherichia coli by an IL-1- and tumor necrosis factor-independent mechanism.
    Gleason TG, Houlgrave CW, May AK, Crabtree TD, Sawyer RG, Denham W, Norman JG, Pruett TL.
    Infect Immun; 1998 Sep 01; 66(9):4215-21. PubMed ID: 9712770
    [Abstract] [Full Text] [Related]

  • 20. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.
    Morigi M, Galbusera M, Gastoldi S, Locatelli M, Buelli S, Pezzotta A, Pagani C, Noris M, Gobbi M, Stravalaci M, Rottoli D, Tedesco F, Remuzzi G, Zoja C.
    J Immunol; 2011 Jul 01; 187(1):172-80. PubMed ID: 21642543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.